Skip to main content
Psomagen, Inc. logo

Psomagen, Inc. — Investor Relations & Filings

Ticker · 950200 ISIN · KR8840150005 KO Professional, scientific and technical activities
Open in API
Filings indexed 180 across all filing types
Latest filing 2024-03-14 AGM Information
Country US United States of America
Listing KO 950200

About Psomagen, Inc.

https://www.psomagen.com/

Psomagen, Inc. is a contract laboratory service provider specializing in multiomics and data analysis solutions for scientists and clinicians. Operating from CLIA-certified and CAP-accredited facilities, the company offers a comprehensive suite of services to the academic, clinical, and life sciences research communities. Its core offerings encompass genomics, epigenomics, proteomics, transcriptomics, and metagenomics. Psomagen utilizes a range of sequencing technologies, including Sanger sequencing, Next-Generation Sequencing (NGS), and third-generation sequencing. The company also provides specialized solutions such as spatial biology analysis, cell line authentication via STR profiling, and advanced bioinformatics support to analyze complex biological data.

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) titled 'Report on the Reason for Holding a General Meeting of Shareholders on a Concentrated Date'. It explains why the company (Psomagen) scheduled its AGM on a date designated as a 'concentrated date' by the KOSDAQ Association. Since this is a regulatory disclosure regarding meeting logistics and compliance rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2024-03-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and the purpose of holding (management influence) for the company 'Somagen' and its major shareholder 'Macrogen'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided taxonomy.
2024-02-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (purchases) made by an executive (정한성) of the company (주)소마젠. This type of filing is a standard regulatory requirement for insider trading/shareholding disclosures, which falls under the 'Director's Dealing' category.
2024-02-19 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (SomaGen) announcing a significant change (over 15-30%) in its financial structure (revenue and profit/loss). This is a standard 'Material Change in Financial Structure' disclosure required by the Korea Exchange (KRX). Since it provides specific financial highlights and explanations for the variance before the final audit report is finalized, it falls under the category of an Earnings Release (ER) or a general regulatory filing. Given the specific nature of the 'Material Change' disclosure, it is best classified as an Earnings Release (ER) as it serves as the initial announcement of financial performance results. FY 2023
2024-02-15 Korean
기타경영사항(자율공시)(제20기 정기주주총회 권리주주 확정을 위한 증권예탁증권 기준일 설정 공고)
AGM Information Classification · 95% confidence The document is a regulatory announcement from Psomagen regarding the setting of a record date for the 20th Annual General Meeting and the suspension of KDR-to-stock conversion. It is a short, formal notice (under 5,000 characters) regarding corporate governance and meeting logistics, which does not fit into specific categories like AGM-R (presentation materials) or PSI (proxy solicitation). It is best classified as a general regulatory filing.
2023-12-15 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and logistics of an Investor Relations (IR) event (기업설명회). It provides the date, time, location (online), target audience, and purpose of the meeting. Since it is an announcement of an upcoming presentation rather than the presentation slides themselves, and it serves as a regulatory notification of corporate activity, it fits best under the 'Regulatory Filings' category as a general announcement.
2023-11-28 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.